Kein Vorteil durch initiale Triple- versus duale Therapie bei inzidenter PAH
Crossref DOI link: https://doi.org/10.1007/s15033-021-2786-9
Published Online: 2021-12-13
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Skowasch, Dirk
Text and Data Mining valid from 2021-12-01
Version of Record valid from 2021-12-01
Article History
First Online: 13 December 2021